MariaTeresaAbreuMD
Gastroenterology • Miami, FLInflammatory Bowel Disease
Professor of Medicine, University Miami School of Medicine
Dr. Abreu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1011 NW 15th St
Gautier 501 (D-149)
Miami, FL 33136Phone+1 305-243-6404Fax+1 305-243-6125
Summary
- Dr. Maria T. Abreu is an IBD expert at the University of Miami Miller School of Medicine. Patient care takes place at the Crohn's and Colitis Clinic at the University of Miami Sylvester Cancer Center. She received her medical degree from University of Miami Miller School of Medicine and has been in practice 27 years. She performs basic and translational research. Her area of interest is innate immune signaling, therapeutic drug monitoring, and the genetics of IBD, esp in Hispanic patients.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1992 - 1995
Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1992
University of Miami Leonard M. Miller School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 2024 - 2027
FL State Medical License 2008 - 2026
NY State Medical License 2004 - 2008
Awards, Honors, & Recognition
- The Sherman Prize The Bruce and Cynthia Sherman Charitable Foundation, 2019
- Elected Member, Association of American Physicians 2018
- America's Top Doctors Castle Connolly, 2008-2014
- Join now to see all
Publications & Presentations
PubMed
- International consensus statement on microbiome testing in clinical practice.Serena Porcari, Benjamin H Mullish, Francesco Asnicar, Siew C Ng, Liping Zhao
The Lancet. Gastroenterology & Hepatology. 2024-12-05 - 6 citationsTwo-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.Bruce E Sands, Geert D'Haens, David B Clemow, Peter M Irving, Jordan T Johns
Inflammatory Bowel Diseases. 2024-12-05 - Gender Inequity in Pharma-Supported Inflammatory Bowel Disease Presentations: Shining a Light on Opportunities for Equality and Transparency in Medical Research.Federica Di Vincenzo, Maria A Quintero, Payton Mendygral, Maria T Abreu
Gastroenterology. 2024-12-01
Press Mentions
Congrats to Dr. Abreu on Her New IBD Director PositionNovember 13th, 2024- Cedars-Sinai Taps New Director of F. Widjaja Inflammatory Bowel Disease InstituteNovember 11th, 2024
- Gastroenterologists Question Benefits, Note Potential Harms of New UHC ProgramOctober 21st, 2024
- Join now to see all
Grant Support
- Role Of TLR4 In Colitis-Associated NeoplasiaNational Cancer Institute2009–2012
- Toll- LIKE Receptor-Complex In Intestinal Epithelial CellsNational Institute Of Allergy And Infectious Diseases2008–2009
- Toll-Like Receptor-Complex In Intestinal Epith. CellsNational Institute Of Allergy And Infectious Diseases2004–2007
- Role Of TLR4 In Acute And Chronic Murine ColitisNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Randomized, Double-Masked, Placebo-Controlled Pilot TRNational Center For Research Resources2004
- Toll-Like Receptor-Complex In Intestinal Epith. CellsNational Institute Of Allergy And Infectious Diseases2003–2004
- Protection From Fas-Mediated Apoptosis In The GutNational Institute Of Diabetes And Digestive And Kidney Diseases2002
- Toll-Like Receptor-Complex In Intestinal CellsNational Institute Of Allergy And Infectious Diseases2002
- Growth And Death Signals In The ProstateNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2002
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
